Skip to Content

Division of Internal Medicine

Our mission is to provide a broad cancer patients with the full spectrum of evidence-based cancer and internal medicine care including treatment, supportive care, survivorship care, and prevention.

Our vision is to continually expand our lead as a patient-centered, research-driven internal medicine division in a comprehensive cancer care center through the recruitment, retention, and development of the finest physicians, scientists, educators and staff.

David Tweardy, M.D.
Division Head, Internal Medicine
Professor of Infectious Diseases and Molecular and Cellular Oncology

Ellen Manzullo, M.D.
Deputy Division Head Clinical
Professor, General Internal Medicine

Dimitrios Kontoyiannis, M.D.
Deputy Division Head Research
Professor, Infectious Diseases, Infection Control and Employee Health

William Atkinson IV
Division Administrator ad interim
Department Administrator, General Internal Medicine

The Division of Internal Medicine comprises nine departments:

It also includes three sections:

  • Benign Hematology
  • Nephrology
  • Rheumatology

In addition to providing clinical excellence in their division practices, faculty members have developed broad-based research programs in their respective subspecialty areas.

New Residency Program

The Baylor College of Medicine/MD Anderson Internal Medicine Residency Program is a unique opportunity in which future internists will be trained to become experts in treating the medical complications of cancer and cancer treatment.

Interested individuals must apply to Baylor College of Medicine through the ERAS system (Electronic Residency Application Service). Once in the Baylor system, select the BCM/MD Anderson Cancer Center track.

Grand Rounds and Conferences

Friday, April 3, 2015, 8-9 a.m., Pickens Tower, Floor 3, Rooms 1,2,7,8
What is the Evidence for Nutrition Support in Oncology?

Todd Canada, Pharm.D., manager, Clinical Pharmacy Services, Pharmacy Clinical Programs


Friday, April 10, 2015, 8-9 a.m., Pickens Tower, Floor 3, Rooms 1,2,7,8
Anemia in Kidney Disease: Harnessing Hypoxia Responses for Therapy

Volker H. Haase, M.D., associate professor of Medicine, associate professor of Molecular
Physiology and Biophysics, Krick-Brooks Chair in Nephrology, associate professor 
of Cancer Biology, Vanderbilt University School of Medicine


Friday, April 17, 2015, 8-9 a.m., Pickens Tower, Floor 3, Rooms 1,2,7,8
CMV in HSCT Recipients and Critically Ill Patients

Michael Boeckh, M.D., Ph.D., professor, Department of Medicine, University of 
Washington; and member, Fred Hutchison Cancer Research Center


Friday, April 24, 2015, 8-9 a.m., Pickens Tower, Floor 3, Rooms 1,2,7,8
Pneumococcal Lung Infection and Host Tolerance

Charles Sun Dela Cruz, M.D., Ph.D., assistant professor of Pulmonary, Critical Care and
Sleep Medicine, Yale School of Medicine

© 2015 The University of Texas MD Anderson Cancer Center